The History of Terrorism
Preview
Open in TheBrain
Links
Peter de Keizer
Children
Cleara Biotech
Cleara's approach, meanwhile, which uses an engineered peptide molecule, targets a particular subtype of senescent cell, which, says scientific co-founder Peter de Keizer, will make it safer.